Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C

Calogero Cammà, Salvatore Petta, Giuseppe Cabibbo, Matteo Ruggeri, Marco Enea, Raffaele Bruno, Vincenza Capursi, Antonio Gasbarrini, Alfredo Alberti, Antonio Craxì

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C'. Together they form a unique fingerprint.

Medicine & Life Sciences